

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.57662947 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.57662947 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.57662947 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.57662947 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.57662947 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.57662947 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.27324740 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.13761673 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07579238 |
| 10 | eosinophil chemotaxis (GO:0048245) | 5.04167505 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.88133206 |
| 12 | pinocytosis (GO:0006907) | 4.73666466 |
| 13 | detection of other organism (GO:0098543) | 4.65031253 |
| 14 | negative regulation of granulocyte differentiation (GO:0030853) | 4.60891468 |
| 15 | adhesion of symbiont to host cell (GO:0044650) | 4.55956048 |
| 16 | virion attachment to host cell (GO:0019062) | 4.55956048 |
| 17 | B cell mediated immunity (GO:0019724) | 4.52607502 |
| 18 | detection of bacterium (GO:0016045) | 4.48077133 |
| 19 | eosinophil migration (GO:0072677) | 4.47096572 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26467353 |
| 21 | regulation of hypersensitivity (GO:0002883) | 4.24515382 |
| 22 | low-density lipoprotein particle clearance (GO:0034383) | 4.13685738 |
| 23 | microglial cell activation (GO:0001774) | 4.11696180 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 4.10415828 |
| 25 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.08756973 |
| 26 | adhesion of symbiont to host (GO:0044406) | 4.04295521 |
| 27 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.02583182 |
| 28 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.99245429 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.97228181 |
| 30 | detection of external biotic stimulus (GO:0098581) | 3.90113980 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86991993 |
| 32 | response to peptidoglycan (GO:0032494) | 3.85429446 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 3.84281699 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.76564410 |
| 35 | T-helper 1 type immune response (GO:0042088) | 3.76015317 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.75004381 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73421482 |
| 38 | lipoxygenase pathway (GO:0019372) | 3.72236059 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69232252 |
| 40 | negative regulation of cell killing (GO:0031342) | 3.69232252 |
| 41 | cellular extravasation (GO:0045123) | 3.68769676 |
| 42 | regulation of cholesterol storage (GO:0010885) | 3.67875093 |
| 43 | positive regulation of type 2 immune response (GO:0002830) | 3.62210054 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60832048 |
| 45 | macrophage activation (GO:0042116) | 3.60822617 |
| 46 | positive regulation of cholesterol efflux (GO:0010875) | 3.54430911 |
| 47 | cellular response to interferon-beta (GO:0035458) | 3.49899132 |
| 48 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.47874075 |
| 49 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.46608105 |
| 50 | glycosphingolipid catabolic process (GO:0046479) | 3.43710672 |
| 51 | positive thymic T cell selection (GO:0045059) | 3.43696645 |
| 52 | leukotriene metabolic process (GO:0006691) | 3.43627321 |
| 53 | detection of biotic stimulus (GO:0009595) | 3.42812890 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.41238039 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38869211 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37601116 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37601116 |
| 58 | negative regulation of phagocytosis (GO:0050765) | 3.37282417 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.33928777 |
| 60 | respiratory burst (GO:0045730) | 3.33742519 |
| 61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.33676920 |
| 62 | negative thymic T cell selection (GO:0045060) | 3.33276532 |
| 63 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.31155511 |
| 64 | T cell costimulation (GO:0031295) | 3.30427170 |
| 65 | mannose metabolic process (GO:0006013) | 3.30193228 |
| 66 | regulation of monocyte chemotaxis (GO:0090025) | 3.28252775 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.28033520 |
| 68 | apoptotic cell clearance (GO:0043277) | 3.27357230 |
| 69 | lymphocyte costimulation (GO:0031294) | 3.26650600 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25493866 |
| 71 | response to host immune response (GO:0052572) | 3.25493866 |
| 72 | myeloid dendritic cell activation (GO:0001773) | 3.24887215 |
| 73 | growth hormone receptor signaling pathway (GO:0060396) | 3.23269868 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.20202881 |
| 75 | cellular response to interferon-gamma (GO:0071346) | 3.19629566 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18211049 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16122974 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 3.15302411 |
| 79 | regulation of type 2 immune response (GO:0002828) | 3.14832843 |
| 80 | positive regulation of regulated secretory pathway (GO:1903307) | 3.13926272 |
| 81 | response to muramyl dipeptide (GO:0032495) | 3.13648864 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 3.12672691 |
| 83 | positive regulation of cholesterol transport (GO:0032376) | 3.11789921 |
| 84 | positive regulation of sterol transport (GO:0032373) | 3.11789921 |
| 85 | glycolipid catabolic process (GO:0019377) | 3.11225316 |
| 86 | negative T cell selection (GO:0043383) | 3.11044918 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09350202 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09031256 |
| 89 | regulation of mononuclear cell migration (GO:0071675) | 3.07753018 |
| 90 | leukotriene biosynthetic process (GO:0019370) | 3.07680397 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 3.06977778 |
| 92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06715573 |
| 93 | complement activation, alternative pathway (GO:0006957) | 3.04018510 |
| 94 | neutrophil activation (GO:0042119) | 3.03492548 |
| 95 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.03465102 |
| 96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03331062 |
| 97 | regulation of macrophage chemotaxis (GO:0010758) | 3.01101381 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01038598 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 3.01038598 |
| 100 | lymphocyte chemotaxis (GO:0048247) | 3.00083582 |
| 101 | negative regulation of T cell mediated immunity (GO:0002710) | 2.99759954 |
| 102 | regulation of mast cell activation (GO:0033003) | 2.99448682 |
| 103 | positive regulation of chemokine secretion (GO:0090197) | 2.99015877 |
| 104 | negative regulation of mast cell activation (GO:0033004) | 2.98812153 |
| 105 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.98510691 |
| 106 | positive regulation of macrophage cytokine production (GO:0060907) | 2.97979713 |
| 107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97318096 |
| 108 | granulocyte activation (GO:0036230) | 2.95246091 |
| 109 | positive regulation of interferon-beta production (GO:0032728) | 2.95082131 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94553481 |
| 111 | negative regulation of lipid storage (GO:0010888) | 2.94087312 |
| 112 | regulation of leukocyte degranulation (GO:0043300) | 2.93917637 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.93326288 |
| 114 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.91556700 |
| 115 | response to host (GO:0075136) | 2.90938066 |
| 116 | response to host defenses (GO:0052200) | 2.90938066 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90938066 |
| 118 | response to interferon-gamma (GO:0034341) | 2.90559384 |
| 119 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.90240816 |
| 120 | positive regulation of B cell differentiation (GO:0045579) | 2.87802251 |
| 121 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83147806 |
| 122 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.82705882 |
| 123 | germinal center formation (GO:0002467) | 2.82493451 |
| 124 | response to protozoan (GO:0001562) | 2.81685433 |
| 125 | negative regulation of macrophage differentiation (GO:0045650) | 2.81465450 |
| 126 | peptide catabolic process (GO:0043171) | 2.81183317 |
| 127 | hyaluronan catabolic process (GO:0030214) | 2.80860395 |
| 128 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.80835487 |
| 129 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.80134789 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79585616 |
| 131 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79248496 |
| 132 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.77896522 |
| 133 | regulation of sequestering of triglyceride (GO:0010889) | 2.77787022 |
| 134 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.77764646 |
| 135 | production of molecular mediator of immune response (GO:0002440) | 2.76429395 |
| 136 | phagocytosis, engulfment (GO:0006911) | 2.75543895 |
| 137 | monocyte chemotaxis (GO:0002548) | 2.75272673 |
| 138 | type I interferon signaling pathway (GO:0060337) | 2.75104847 |
| 139 | cellular response to type I interferon (GO:0071357) | 2.75104847 |
| 140 | myeloid dendritic cell differentiation (GO:0043011) | 2.74578756 |
| 141 | positive regulation of leukocyte degranulation (GO:0043302) | 2.74458736 |
| 142 | regulation of macrophage differentiation (GO:0045649) | 2.74076217 |
| 143 | positive regulation of lymphocyte migration (GO:2000403) | 2.73957993 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.73539310 |
| 145 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.72549128 |
| 146 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.71200588 |
| 147 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.70538061 |
| 148 | cellular response to growth hormone stimulus (GO:0071378) | 2.69337502 |
| 149 | response to type I interferon (GO:0034340) | 2.69280843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.64199040 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.07413074 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.10360563 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.48709560 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.22843449 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72585960 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.56271674 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.16991957 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06010019 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02304638 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.97939639 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95226787 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.51139511 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.44457297 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.38754912 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30128777 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28249334 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.27761022 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11712427 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.11054226 |
| 21 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.09162816 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08622947 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98169680 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.94447580 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92989084 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91760080 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88300032 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84503141 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81025818 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80880659 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78324558 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77646141 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76729019 |
| 34 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73892703 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73419698 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69066543 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67857746 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66574962 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65803649 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.65452748 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62559256 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62159938 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.55010592 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54679928 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.51434748 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49663316 |
| 47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49118372 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43847161 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39437044 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39417698 |
| 51 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37668392 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37426253 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35720929 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.32317177 |
| 55 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31649696 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30187560 |
| 57 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30100347 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30028335 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27825616 |
| 60 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24555346 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22089713 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20645451 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18978056 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18654920 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17944035 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.14567022 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13638537 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12860352 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12015029 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10682446 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09787394 |
| 72 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.09320182 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09167491 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04836102 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04743427 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00888259 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00273654 |
| 78 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.99572987 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 0.98520732 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97979724 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95881491 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95721800 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95720904 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94611674 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94002107 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93532007 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91726932 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90646620 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89924202 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89901002 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89345088 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89193454 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89065753 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88471407 |
| 95 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87911626 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87474294 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87442572 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86999400 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81963041 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81238946 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80528649 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80155400 |
| 103 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80125782 |
| 104 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.80097744 |
| 105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79924406 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79918025 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79435755 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79305617 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78338824 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77294512 |
| 111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76936774 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76760645 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.76481133 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75729954 |
| 115 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75720269 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75136738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.81441156 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.85218511 |
| 3 | MP0003436_decreased_susceptibility_to | 3.20237099 |
| 4 | MP0009840_abnormal_foam_cell | 3.10395759 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.09465876 |
| 6 | MP0002419_abnormal_innate_immunity | 2.88398942 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.86008169 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.78744311 |
| 9 | MP0003303_peritoneal_inflammation | 2.41604741 |
| 10 | MP0005025_abnormal_response_to | 2.41497955 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.39287867 |
| 12 | MP0005670_abnormal_white_adipose | 2.26399193 |
| 13 | MP0009785_altered_susceptibility_to | 2.22935050 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.19842163 |
| 15 | MP0001790_abnormal_immune_system | 2.17237734 |
| 16 | MP0005387_immune_system_phenotype | 2.17237734 |
| 17 | MP0000685_abnormal_immune_system | 2.16829583 |
| 18 | MP0000343_altered_response_to | 2.13737460 |
| 19 | MP0008004_abnormal_stomach_pH | 2.11161231 |
| 20 | MP0005275_abnormal_skin_tensile | 2.09415541 |
| 21 | MP0003690_abnormal_glial_cell | 2.06444743 |
| 22 | MP0003724_increased_susceptibility_to | 2.05155583 |
| 23 | MP0001800_abnormal_humoral_immune | 2.02624530 |
| 24 | MP0001853_heart_inflammation | 1.95602323 |
| 25 | MP0002723_abnormal_immune_serum | 1.92222753 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.91679169 |
| 27 | MP0005671_abnormal_response_to | 1.84120547 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.83229998 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.81076524 |
| 30 | MP0001819_abnormal_immune_cell | 1.80761379 |
| 31 | MP0004510_myositis | 1.80267797 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.80214501 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.77444271 |
| 34 | MP0000604_amyloidosis | 1.74197237 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.71761388 |
| 36 | MP0004130_abnormal_muscle_cell | 1.66795035 |
| 37 | MP0002405_respiratory_system_inflammati | 1.65542741 |
| 38 | MP0006082_CNS_inflammation | 1.65142682 |
| 39 | MP0003448_altered_tumor_morphology | 1.60610199 |
| 40 | MP0002254_reproductive_system_inflammat | 1.60566542 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.55661355 |
| 42 | MP0004947_skin_inflammation | 1.53422282 |
| 43 | MP0003828_pulmonary_edema | 1.53271245 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.51291021 |
| 45 | MP0003075_altered_response_to | 1.51079332 |
| 46 | MP0008469_abnormal_protein_level | 1.43416707 |
| 47 | MP0009764_decreased_sensitivity_to | 1.36175828 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.30822792 |
| 49 | MP0001958_emphysema | 1.30212799 |
| 50 | MP0005360_urolithiasis | 1.28673580 |
| 51 | MP0005647_abnormal_sex_gland | 1.28370100 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.27202607 |
| 53 | MP0005310_abnormal_salivary_gland | 1.26842731 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.22572652 |
| 55 | MP0003866_abnormal_defecation | 1.22210105 |
| 56 | * MP0000716_abnormal_immune_system | 1.21517822 |
| 57 | MP0001727_abnormal_embryo_implantation | 1.18886846 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.18582336 |
| 59 | MP0002909_abnormal_adrenal_gland | 1.18282629 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.17104421 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.17003691 |
| 62 | MP0010307_abnormal_tumor_latency | 1.13993091 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.12327281 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.11802613 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.11157954 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.10216747 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.08407319 |
| 68 | MP0008260_abnormal_autophagy | 1.08261087 |
| 69 | MP0002006_tumorigenesis | 1.07987731 |
| 70 | MP0009115_abnormal_fat_cell | 1.07957713 |
| 71 | MP0001986_abnormal_taste_sensitivity | 1.07467883 |
| 72 | MP0000858_altered_metastatic_potential | 1.06383641 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.05185134 |
| 74 | * MP0002398_abnormal_bone_marrow | 1.03560306 |
| 75 | MP0001851_eye_inflammation | 1.03149151 |
| 76 | MP0000249_abnormal_blood_vessel | 1.02831812 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.02442034 |
| 78 | MP0002060_abnormal_skin_morphology | 1.00241337 |
| 79 | MP0002971_abnormal_brown_adipose | 0.99305802 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.99155289 |
| 81 | * MP0002429_abnormal_blood_cell | 0.99076791 |
| 82 | MP0005451_abnormal_body_composition | 0.98503995 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.98180007 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.97559403 |
| 85 | MP0002722_abnormal_immune_system | 0.97350315 |
| 86 | MP0005166_decreased_susceptibility_to | 0.96447721 |
| 87 | MP0000920_abnormal_myelination | 0.93090422 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.93003368 |
| 89 | MP0005334_abnormal_fat_pad | 0.92374065 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.91324790 |
| 91 | MP0005164_abnormal_response_to | 0.90214710 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.90008507 |
| 93 | MP0009763_increased_sensitivity_to | 0.89944416 |
| 94 | MP0004883_abnormal_blood_vessel | 0.89463525 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.88066583 |
| 96 | MP0000609_abnormal_liver_physiology | 0.86816916 |
| 97 | MP0005390_skeleton_phenotype | 0.86138934 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.84382128 |
| 99 | MP0002796_impaired_skin_barrier | 0.83907121 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.82298106 |
| 101 | MP0001545_abnormal_hematopoietic_system | 0.82298106 |
| 102 | MP0002396_abnormal_hematopoietic_system | 0.82105503 |
| 103 | MP0005365_abnormal_bile_salt | 0.81071424 |
| 104 | MP0003279_aneurysm | 0.79010764 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.78539383 |
| 106 | MP0003795_abnormal_bone_structure | 0.78248168 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.76933920 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.75873172 |
| 109 | MP0001243_abnormal_dermal_layer | 0.75834519 |
| 110 | MP0001542_abnormal_bone_strength | 0.75612929 |
| 111 | MP0005165_increased_susceptibility_to | 0.74787048 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.74528163 |
| 113 | MP0002132_abnormal_respiratory_system | 0.74455463 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.74414528 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.74078253 |
| 116 | MP0003186_abnormal_redox_activity | 0.73121737 |
| 117 | MP0009278_abnormal_bone_marrow | 0.70809255 |
| 118 | MP0001915_intracranial_hemorrhage | 0.70514096 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.69561417 |
| 120 | MP0003091_abnormal_cell_migration | 0.68540173 |
| 121 | MP0002277_abnormal_respiratory_mucosa | 0.66260526 |
| 122 | MP0008874_decreased_physiological_sensi | 0.66238408 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.66233686 |
| 124 | MP0001663_abnormal_digestive_system | 0.65809156 |
| 125 | MP0003879_abnormal_hair_cell | 0.65587117 |
| 126 | MP0000490_abnormal_crypts_of | 0.63036133 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61985749 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.59340751 |
| 129 | MP0000371_diluted_coat_color | 0.57101430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.94711932 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.66630815 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.25907337 |
| 4 | Glomerulonephritis (HP:0000099) | 5.48310804 |
| 5 | Complement deficiency (HP:0004431) | 5.11162265 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.92116291 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.87666361 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.86439657 |
| 9 | Abnormality of complement system (HP:0005339) | 4.70834282 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.69720698 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.40593632 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.06175900 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90660870 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90660870 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90660870 |
| 16 | Disinhibition (HP:0000734) | 3.89177075 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.85793127 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82173882 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82173882 |
| 20 | Hematochezia (HP:0002573) | 3.76260342 |
| 21 | Amyloidosis (HP:0011034) | 3.50908421 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.48419849 |
| 23 | Mucopolysacchariduria (HP:0008155) | 3.48419849 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.45295043 |
| 25 | Axonal loss (HP:0003447) | 3.41175394 |
| 26 | Meningitis (HP:0001287) | 3.41143847 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.33475587 |
| 28 | Nephritis (HP:0000123) | 3.30045805 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29857083 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29857083 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29857083 |
| 32 | Neurofibrillary tangles (HP:0002185) | 3.27502089 |
| 33 | Recurrent skin infections (HP:0001581) | 3.24655416 |
| 34 | Mutism (HP:0002300) | 3.23615735 |
| 35 | Myocardial infarction (HP:0001658) | 3.19262902 |
| 36 | Prostate neoplasm (HP:0100787) | 3.18045281 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 3.15879515 |
| 38 | Myositis (HP:0100614) | 3.15472615 |
| 39 | Thick nail (HP:0001805) | 3.09973877 |
| 40 | Hemoptysis (HP:0002105) | 3.09097033 |
| 41 | Colitis (HP:0002583) | 3.04646651 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02656096 |
| 43 | Spondylolisthesis (HP:0003302) | 2.94373539 |
| 44 | Urticaria (HP:0001025) | 2.86398789 |
| 45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.82580551 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.82580551 |
| 47 | Chest pain (HP:0100749) | 2.75232651 |
| 48 | Gingivitis (HP:0000230) | 2.74587767 |
| 49 | Vasculitis (HP:0002633) | 2.73063028 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.67268475 |
| 51 | Agnosia (HP:0010524) | 2.61381146 |
| 52 | Loss of speech (HP:0002371) | 2.54053099 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.53146748 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.50439247 |
| 55 | Purpura (HP:0000979) | 2.50278636 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.49360131 |
| 57 | Esophageal varix (HP:0002040) | 2.45980159 |
| 58 | Epistaxis (HP:0000421) | 2.45391875 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.44965041 |
| 60 | Premature loss of primary teeth (HP:0006323) | 2.43926367 |
| 61 | Polygenic inheritance (HP:0010982) | 2.40644216 |
| 62 | Obstructive lung disease (HP:0006536) | 2.39579981 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39579981 |
| 64 | Encephalitis (HP:0002383) | 2.38747512 |
| 65 | Pustule (HP:0200039) | 2.38744991 |
| 66 | Orchitis (HP:0100796) | 2.37999971 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.36928972 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.36814683 |
| 69 | Malnutrition (HP:0004395) | 2.32212192 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31545634 |
| 71 | Petechiae (HP:0000967) | 2.31455217 |
| 72 | Recurrent viral infections (HP:0004429) | 2.29931554 |
| 73 | Upper motor neuron abnormality (HP:0002127) | 2.24256583 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.19357931 |
| 75 | Gingival bleeding (HP:0000225) | 2.18171087 |
| 76 | Polyneuropathy (HP:0001271) | 2.17546429 |
| 77 | Cheilitis (HP:0100825) | 2.17525030 |
| 78 | Progressive visual loss (HP:0000529) | 2.17030698 |
| 79 | Pulmonary embolism (HP:0002204) | 2.15663151 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.15134862 |
| 81 | Thrombocytosis (HP:0001894) | 2.15081904 |
| 82 | Abnormality of the lumbar spine (HP:0100712) | 2.13857362 |
| 83 | Conjunctival telangiectasia (HP:0000524) | 2.12629252 |
| 84 | Cellulitis (HP:0100658) | 2.10878755 |
| 85 | Memory impairment (HP:0002354) | 2.09525837 |
| 86 | T lymphocytopenia (HP:0005403) | 2.09376630 |
| 87 | Protuberant abdomen (HP:0001538) | 2.09241757 |
| 88 | Periodontitis (HP:0000704) | 2.08730165 |
| 89 | Hypertriglyceridemia (HP:0002155) | 2.04585686 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04008802 |
| 91 | Gangrene (HP:0100758) | 2.03601936 |
| 92 | Amaurosis fugax (HP:0100576) | 2.03544384 |
| 93 | Mucosal telangiectasiae (HP:0100579) | 2.02461193 |
| 94 | Personality changes (HP:0000751) | 2.02377262 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 2.01660435 |
| 96 | Xerostomia (HP:0000217) | 2.00682251 |
| 97 | Oligomenorrhea (HP:0000876) | 2.00146177 |
| 98 | Absent frontal sinuses (HP:0002688) | 1.97053093 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.96074073 |
| 100 | Syringomyelia (HP:0003396) | 1.95830076 |
| 101 | Spinal cord lesions (HP:0100561) | 1.95830076 |
| 102 | Keratoconjunctivitis (HP:0001096) | 1.94438761 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.94124639 |
| 104 | Vertigo (HP:0002321) | 1.93791785 |
| 105 | Steatorrhea (HP:0002570) | 1.93485516 |
| 106 | Diminished motivation (HP:0000745) | 1.93296297 |
| 107 | Basal ganglia calcification (HP:0002135) | 1.93114582 |
| 108 | Apathy (HP:0000741) | 1.89866862 |
| 109 | Joint stiffness (HP:0001387) | 1.88578169 |
| 110 | Bone cyst (HP:0012062) | 1.88532729 |
| 111 | Leukocytosis (HP:0001974) | 1.86478027 |
| 112 | Pulmonary infiltrates (HP:0002113) | 1.86199478 |
| 113 | Stomatitis (HP:0010280) | 1.83291885 |
| 114 | Peritonitis (HP:0002586) | 1.83071575 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 1.80319673 |
| 116 | Optic neuritis (HP:0100653) | 1.80319673 |
| 117 | Peripheral demyelination (HP:0011096) | 1.79961616 |
| 118 | Facial diplegia (HP:0001349) | 1.79471185 |
| 119 | Ovoid vertebral bodies (HP:0003300) | 1.77438329 |
| 120 | Supranuclear gaze palsy (HP:0000605) | 1.76920646 |
| 121 | Increased IgE level (HP:0003212) | 1.75688087 |
| 122 | Pathologic fracture (HP:0002756) | 1.75058884 |
| 123 | Keratoconjunctivitis sicca (HP:0001097) | 1.74873827 |
| 124 | Inappropriate behavior (HP:0000719) | 1.74828744 |
| 125 | Chronic otitis media (HP:0000389) | 1.74362651 |
| 126 | Abnormality of the prostate (HP:0008775) | 1.73500966 |
| 127 | Joint hemorrhage (HP:0005261) | 1.73333706 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 1.71395992 |
| 129 | Osteomyelitis (HP:0002754) | 1.69878450 |
| 130 | Arterial thrombosis (HP:0004420) | 1.69601944 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.68495071 |
| 132 | Abnormality of nail color (HP:0100643) | 1.67662679 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.67440234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.04738811 |
| 2 | TYK2 | 4.79748817 |
| 3 | MAP3K13 | 3.24215643 |
| 4 | TGFBR2 | 3.16462573 |
| 5 | TRIB3 | 2.98661139 |
| 6 | IRAK3 | 2.98560535 |
| 7 | TBK1 | 2.80238249 |
| 8 | IRAK4 | 2.75262416 |
| 9 | RIPK4 | 2.45388071 |
| 10 | MAP3K14 | 2.43245479 |
| 11 | CAMK1D | 2.42393262 |
| 12 | CSF1R | 2.31000719 |
| 13 | KIT | 2.23563349 |
| 14 | CLK1 | 2.06697262 |
| 15 | STK10 | 2.04299812 |
| 16 | JAK1 | 2.01990248 |
| 17 | ERN1 | 2.01768426 |
| 18 | GRK7 | 2.01419589 |
| 19 | PRPF4B | 1.98477773 |
| 20 | MAP4K1 | 1.90048551 |
| 21 | FGR | 1.80252549 |
| 22 | TAOK3 | 1.78162800 |
| 23 | JAK3 | 1.75346231 |
| 24 | ARAF | 1.67566145 |
| 25 | SCYL2 | 1.57239629 |
| 26 | CSK | 1.53795778 |
| 27 | IKBKB | 1.47452242 |
| 28 | ZAP70 | 1.45511622 |
| 29 | MAP2K3 | 1.45151718 |
| 30 | TTN | 1.45057510 |
| 31 | CDK19 | 1.43320966 |
| 32 | CAMK1G | 1.43068718 |
| 33 | ITK | 1.42658046 |
| 34 | TXK | 1.36980493 |
| 35 | EPHB1 | 1.32356433 |
| 36 | RIPK1 | 1.31791246 |
| 37 | IKBKE | 1.31586454 |
| 38 | MET | 1.28794042 |
| 39 | BMX | 1.28518962 |
| 40 | KSR2 | 1.25220810 |
| 41 | MST1R | 1.23824128 |
| 42 | CDC42BPA | 1.22475764 |
| 43 | TNK2 | 1.22270278 |
| 44 | JAK2 | 1.19265634 |
| 45 | FES | 1.18838437 |
| 46 | MAP3K6 | 1.17554401 |
| 47 | MAP3K1 | 1.15207945 |
| 48 | BMPR1B | 1.13924156 |
| 49 | MAP3K10 | 1.13255537 |
| 50 | NEK9 | 1.12472784 |
| 51 | LRRK2 | 1.00612568 |
| 52 | TEC | 0.98946742 |
| 53 | MOS | 0.98536377 |
| 54 | FLT3 | 0.96518857 |
| 55 | HCK | 0.94612713 |
| 56 | STK24 | 0.92426101 |
| 57 | GRK6 | 0.92146839 |
| 58 | LCK | 0.92135777 |
| 59 | SYK | 0.91838504 |
| 60 | MARK3 | 0.89729072 |
| 61 | LYN | 0.88068252 |
| 62 | BTK | 0.85457330 |
| 63 | CDK6 | 0.81245853 |
| 64 | TESK2 | 0.79212577 |
| 65 | YES1 | 0.78923093 |
| 66 | EIF2AK2 | 0.75993731 |
| 67 | PIK3CG | 0.73070097 |
| 68 | MAPK7 | 0.70981432 |
| 69 | PKN2 | 0.69332754 |
| 70 | FGFR3 | 0.68163127 |
| 71 | EGFR | 0.67249524 |
| 72 | DMPK | 0.65648416 |
| 73 | TAOK1 | 0.65415998 |
| 74 | MAP3K9 | 0.65295941 |
| 75 | TRPM7 | 0.65103757 |
| 76 | CHUK | 0.64570218 |
| 77 | PRKCQ | 0.63211504 |
| 78 | PDGFRB | 0.60659941 |
| 79 | TAOK2 | 0.60574176 |
| 80 | MAPKAPK2 | 0.60365340 |
| 81 | MAPK12 | 0.60262569 |
| 82 | ACVR1B | 0.60054877 |
| 83 | MAP3K3 | 0.59726968 |
| 84 | CDK12 | 0.59490372 |
| 85 | ABL2 | 0.57641835 |
| 86 | MATK | 0.53009814 |
| 87 | PTK2B | 0.52429161 |
| 88 | BRSK2 | 0.50674330 |
| 89 | RPS6KA2 | 0.49155011 |
| 90 | MAPK4 | 0.47522311 |
| 91 | PRKCD | 0.47445742 |
| 92 | MAP3K2 | 0.47192212 |
| 93 | SIK3 | 0.45966957 |
| 94 | PTK6 | 0.44535049 |
| 95 | EEF2K | 0.44438727 |
| 96 | DAPK2 | 0.44327050 |
| 97 | IGF1R | 0.44314874 |
| 98 | RPS6KC1 | 0.43971127 |
| 99 | RPS6KL1 | 0.43971127 |
| 100 | RAF1 | 0.43926039 |
| 101 | MAP3K12 | 0.43395884 |
| 102 | RPS6KA4 | 0.42967560 |
| 103 | PDK1 | 0.42001573 |
| 104 | ABL1 | 0.41868810 |
| 105 | PKN1 | 0.40871340 |
| 106 | BMPR2 | 0.40849095 |
| 107 | MAP3K8 | 0.40337932 |
| 108 | PIM1 | 0.40327484 |
| 109 | KDR | 0.39571034 |
| 110 | CDK9 | 0.38840101 |
| 111 | IRAK1 | 0.37218576 |
| 112 | PDPK1 | 0.36654412 |
| 113 | STK4 | 0.36597095 |
| 114 | DYRK1B | 0.36446239 |
| 115 | STK3 | 0.34894926 |
| 116 | KSR1 | 0.34677544 |
| 117 | RET | 0.34464509 |
| 118 | PAK4 | 0.33944896 |
| 119 | GSK3A | 0.33764821 |
| 120 | SGK3 | 0.33696036 |
| 121 | RPS6KA6 | 0.33621917 |
| 122 | CAMKK2 | 0.33016609 |
| 123 | IRAK2 | 0.32896422 |
| 124 | PRKG2 | 0.32851146 |
| 125 | NME2 | 0.32505510 |
| 126 | PRKAA2 | 0.32033842 |
| 127 | PIK3CA | 0.31729897 |
| 128 | CAMKK1 | 0.30241889 |
| 129 | PIM2 | 0.29075958 |
| 130 | TGFBR1 | 0.28874018 |
| 131 | MARK2 | 0.28330438 |
| 132 | MAP3K11 | 0.26924201 |
| 133 | FYN | 0.26335173 |
| 134 | ADRBK2 | 0.25498964 |
| 135 | MAPK3 | 0.25337586 |
| 136 | NTRK1 | 0.25217473 |
| 137 | MAP3K5 | 0.24799460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.06642339 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.88647191 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.76527327 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.57827764 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.10743954 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.05144543 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81639969 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.71532616 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40876042 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.30191274 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27954978 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.92360738 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91091521 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.87580112 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69420164 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61986566 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.61639345 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59185107 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52794678 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52060136 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50748798 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.48845920 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46768717 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44557913 |
| 25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37975957 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.29795004 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27419259 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.22165830 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21682879 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20911882 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.20690229 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18122139 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12760328 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.12753639 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09864938 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.09605949 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08926441 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08066376 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06208514 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06136280 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05652422 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05052723 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01295919 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99345295 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99015164 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95038275 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.92294931 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91366291 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89964953 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.89633594 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86849588 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86614429 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86359338 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85849314 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83421732 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81935647 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.81419868 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76073770 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75279145 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73097628 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72916596 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71853252 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.69857325 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.67462247 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.66276206 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.65053299 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64854104 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61707904 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58651964 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58642563 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.56641619 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55505541 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54394213 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52823222 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.52798045 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50192479 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49275943 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49007000 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48669586 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45653314 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43786660 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43760047 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43630518 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43544196 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43285967 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42914543 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42413378 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42220001 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40981231 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40428595 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40106020 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38917258 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36967769 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36799858 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36468378 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36378076 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36359423 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35834313 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33146488 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.32525897 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26255818 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25905625 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.24729624 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24479116 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23924072 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.23810745 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22847290 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22835872 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22619643 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20580974 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18447458 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17599733 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16150447 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.14489000 |
| 115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.09960440 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.08335580 |

